Skip to main content
# Title Department Research Year
331 Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity Department of Pharmaceutical Organic Chemistry 2020
332 Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Department of Pharmaceutical Organic Chemistry 2020
333 Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients Department of Pharmaceutics 2020
334 Sulpiride Gastro-retentive Floating Microsponges; Analytical study, In vitro Optimization and In vivo Characterization Department of Pharmaceutical Analytical Chemistry 2020
335 Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent Anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes Department of Pharmaceutical Organic Chemistry 2020
336 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
337 New antimicrobial and cytotoxic benzofuran glucoside from Senecio glaucus L Department of Pharmacognosy 2020
338 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers 2020
339 Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate–4-thiazolinone hybrid derivatives
Author links open
Department of Pharmaceutical Organic Chemistry 2020
340 Nanostructured Lipid Carriers to Mediate Brain
Delivery of Temazepam: Design and In Vivo Study
Department of Pharmaceutics 2020